High prevalence of amantadine resistance among circulating European porcine in fluenza A viruses

Journal of General Virology

Volumn 90, Issue 4, 2009, Pages 900-908

  Krumbholz, Andi ^a   Schmidtke, Michaela ^a   Bergmann, Silke ^a   Motzke, Susann ^a   Bauer, Katja ^a   Stech, Jürgen ^b   Dürrwald, Ralf ^c   Wutzler, Peter ^a   Zell, Roland ^a  

^a JENA UNIVERSITY HOSPITAL   (Germany)

^b FEDERAL RESEARCH INSTITUTE FOR ANIMAL HEALTH   (Germany)

^c IDT Biologika GmbH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMANTADINE; ANTIVIRUS AGENT; VIRUS RNA;

ANTIMALARIAL DRUG SUSCEPTIBILITY; ANTIVIRAL ACTIVITY; ARTICLE; CODON; GENETIC ANALYSIS; GENOTYPE; INFLUENZA VIRUS A; NONHUMAN; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; PHYLOGENY; PREVALENCE; PRIORITY JOURNAL; RNA SEQUENCE; VIRUS RESISTANCE; VIRUS STRAIN; VIRUS VIABILITY; ANIMAL; ANIMAL DISEASE; ANTIVIRAL RESISTANCE; CELL LINE; CLASSIFICATION; DNA SEQUENCE; DRUG EFFECT; EPIDEMIOLOGY; EUROPE; GENETICS; INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS A H3N2; ISOLATION AND PURIFICATION; MICROBIOLOGICAL EXAMINATION; MOLECULAR GENETICS; ORTHOMYXOVIRUS INFECTION; SWINE; SWINE DISEASE; VIROLOGY;

AVES; INFLUENZA A VIRUS; SUS;

AMANTADINE; ANIMALS; ANTIVIRAL AGENTS; CELL LINE; DRUG RESISTANCE, VIRAL; EPIDEMIOLOGY, MOLECULAR; EUROPE; INFLUENZA A VIRUS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA A VIRUS, H3N2 SUBTYPE; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; ORTHOMYXOVIRIDAE INFECTIONS; PHYLOGENY; RNA, VIRAL; SEQUENCE ANALYSIS, DNA; SWINE; SWINE DISEASES;

EID: 65549106876     PISSN: 00221317     EISSN: 14652099     Source Type: Journal    
DOI: 10.1099/vir.2008.007260-0     Document Type: Article

References (38)

1. Abed, Y., Goyette, N. & Boivin, G. (2005). Generation and characterization of recombinant influenza A (H1N1) viruses harboring amantadine resistance mutations. Antimicrob Agents Chemother 49, 556-559.
2. Astrahan, P., Kass, I., Cooper, M. A. & Arkin, I. T. (2004). A novel method of resistance for influenza against a channel-blocking antiviral drug. Proteins 55, 251-257.
3. Bright, R. A., Medina, M. J., Xu, X., Perez-Oronoz, G., Wallis, T. R., Davis, X. R., Pavinelli, L., Cox, N. J. & Klimov, A. I. (2005). Incidence of adamantane resistance among influenza A (H3N2) viruses isolated worldwide from 1994 to 2005: A cause for concern. Lancet 366, 1175-1181.
4. Brown, I. H. (2000). The epidemiology and evolution of influenza viruses in pigs. Vet Microbiol 74, 29-46.
5. Brown, I. H., Ludwig, S., Olsen, C. W., Hannoun, C., Scholtissek, C., Hinshaw, V. S., Harris, P. A., McCauley, J. W., Strong, I. & Alexander, D. J. (1997). Antigenic and genetic analyses of H1N1 influenza A viruses from European pigs. J Gen Virol 78, 553-562.
6. Brown, I. H., Harris, P. A., McCauley, J. W. & Alexander, D. J. (1998). Multiple genetic reassortment of avian and human influenza A viruses in European pigs, resulting in the emergence of an H1N2 virus of novel genotype. J Gen Virol 79, 2947-2955.
7. Claas, E. C. J., Kawaoka, Y., De Jong, J. C., Masurel, N. & Webster, R. G. (1994). Infection of children with avian-human reassortant influenza virus from pigs in Europe. Virology 204, 453-457.
8. Deyde, V. M., Xu, X., Bright, R. A., Shaw, M., Smith, C. B., Zhang, Y., Shu, Y., Gubarewa, L. V., Cox, N. J. & Kimov, A. I. (2007). Surveillance of resistance to adamantanes among influenza A(H3N2) and A(H1N1) viruses isolated worldwide. J Infect Dis 196, 249-257.
9. Domingo, E. & Holland, J. J. (1997). RNA virus mutations and fitness for survival. Annu Rev Microbiol 51, 151-178.
10. Drummond, A. J. & Rambaut, A. (2007). BEAST: Bayesian evolutionary analysis by sampling trees. BMC Evol Biol 7, 214.
11. Gregory, V., Lim, W., Cameron, K., Bennett, M., Klimov, A., Hall, H., Cox, N., Hay, A. J. & Lin, Y. (2001). Infection of a child in Hong Kong by an influenza A H3N2 virus closely related to viruses circulating in European pigs. J Gen Virol 82, 1397-1406.
12. Gregory, V., Bennett, M., Thomas, Y., Kaiser, L., Wunderli, W., Matter, H., Hay, A. & Lin, Y. P. (2003). Human infection by a swine influenza A (H1N1) virus in Switzerland. Arch Virol 148, 793-802.
13. Hay, A. J., Wolstenholme, A. J., Skehel, J. J. & Smith, M. H. (1985). The molecular basis of the specific anti-influenza action of amantadine. EMBO J 4, 3021-3024.
14. Hayden, F. G. (2006). Antivirals for influenza: Historical perspectives and lessons learned. Antiviral Res 71, 372-378.
15. Hoffmann, E., Neumann, G., Kawaoka, Y., Hobom, G. & Webster, R. G. (2000). A DNA transfection system for generation of influenza A virus from eight plasmids. Proc Natl Acad Sci U S A 97, 6108-6113.
16. Hurt, A. C., Selleck, P., Komadina, N., Shaw, R., Brown, L. & Barr, I. G. (2007). Susceptibility of highly pathogenic A(H5N1) avian influenza viruses to the neuraminidase inhibitors and adamantanes. Antiviral Res 73, 228-231.
17. Kosakovsky Pond, S. L. & Frost, S. D. W. (2005). Datamonkey: rapid detection of selective pressure on individual sites of codon alignments. Bioinformatics 21, 2531-2533.
18. Li, K. S., Guan, Y., Wang, J., Smith, G. J., Xu, K. M., Duan, L., Rahardjo, A. P., Puthavathana, P., Buranathai, C. & other authors (2004). Genesis of a highly pathogenic and potentially pandemic H5N1 influenza virus in eastern Asia. Nature 430, 209-213.
19. Lu, G., Rowley, T., Garten, R. & Donis, R. O. (2007). FluGenome: A web tool for genotyping influenza A virus. Nucleic Acids Res 35, W275-W279.
20. Ludwig, S., Stitz, L., Planz, O., Van, H., Fitch, W. M. & Scholtissek, S. (1995). European swine virus as a possible source for the next influenza pandemic? Virology 212, 555-561.
21. Marozin, S., Gregory, V., Cameron, K., Bennett, M., Valette, M., Aymard, M., Foni, E., Barigazzi, G., Lin, Y. & Hay, A. (2002). Antigenic and genetic diversity among swine influenza A H1N1 and H1N2 viruses in Europe. J Gen Virol 83, 735-745.
22. Masuda, H., Suzuki, H., Oshitani, H., Saito, R., Kawasaki, S., Nishikawa, M. & Satoh, H. (2000). Incidence of amantadine-resistant influenza A viruses in sentinel surveillance sites and nursing homes in Niigata, Japan. Microbiol Immunol 44, 833-839.
23. Nardelli, L., Pascucci, S., Gualandi, G. L. & Loda, P. (1978). Outbreaks of classical swine influenza in Italy in 1976. Zentralbl Veterinarmed B 25, 853-857.
24. Page, R. D. M. (1996). TreeView: An application to display phylogenetic trees on personal computers. Comput Appl Biosci 12, 357-358.
25. Pensaert, M., Ottis, K., Vandeputte, J., Kaplan, M. M. & Bachmann, P. A. (1981). Evidence for the natural transmission of influenza A virus from wild ducks to swine and its potential importance for man. Bull World Health Organ 59, 75-78.
26. Poon, A. F. Y., Lewis, F. I., Kosakovsky Pond, S. L. & Frost, S. D. W. (2007). An evolutionary-network model reveals stratified interactions in the V3 loop of the HIV-1 envelope. PLoS Comput Biol 3, e231.
27. Posada, D. & Crandall, K. A. (1998). MODELTEST: Testing the model of DNA substitution. Bioinformatics 14, 817-818.
28. Rimmelzwaan, G. F., de Jong, J. C., Bestebroer, T. M., van Loon, A. M., Claas, E. C. J., Fouchier, R. A. M. & Osterhaus, A. D. M. E. (2001). Antigenic and genetic characterization of swine influenza A (H1N1) viruses isolated from pneumonia patients in the Netherlands. Virology 282, 301-308.
29. Ronquist, F. & Huelsenbeck, J. P. (2003). MrBayes 3: Bayesian phylogenetic inference under mixed models. Bioinformatics 19, 1572-1574.
30. Schmidtke, M., Zell, R., Bauer, K., Krumbholz, A., Schrader, C., Süss, J. & Wutzler, P. (2006). Amantadine resistance among porcine H1N1, H1N2, and H3N2 influenza A viruses isolated in Germany between 1981 and 2001. Intervirology 49, 286-293.
31. Schmidtke, M., Bauer, K., Ludwig, N. & Wutzler, P. (2008). Emergence and phylogenetic relationships of amantadine-resistant human H3N2 influenza A viruses in Germany in the season 2005/2006. Int J Antimicrob Agents 32, 192-198.
32. Schnell, J. R. & Chou, J. J. (2008). Structure and mechanism of the M2 proton channel of influenza A virus. Nature 451, 591-595.
33. Shiraishi, K., Mitamura, K., Sakai-Tagawa, Y., Goto, H., Sugaya, N. & Kawaoka, Y. (2003). High frequency of resistant viruses harboring different mutations in amantadine-treated children with influenza. J Infect Dis 188, 57-61.
34. Simonsen, L., Viboud, C., Grenfell, B. T., Dushoff, J., Jennings, L., Smit, M., Macken, C., Hata, M., Gog, J. & other authors (2007). The genesis and spread of reassortment human influenza A/H3N2 viruses conferring adamantane resistance. Mol Biol Evol 24, 1811-1820.
35. Stouffer, A. L., Acharya, R., Salom, D., Levine, A. S., Di Constanzo, L., Soto, C. S., Tereshko, V., Nanda, V., Stayrock, S. & DeGrado, W. F. (2008). Structural basis for the function and inhibition of an influenza virus proton channel. Nature 451, 596-599.
36. Tamura, K., Dudley, J., Nei, M. & Kumar, S. (2007). MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0. Mol Biol Evol 24, 1596-1599.
37. Zell, R., Motzke, S., Krumbholz, A., Wutzler, P., Herwig, V. & Dürrwald, R. (2008). Novel reassortant of swine influenza H1N2 virus in Germany. J Gen Virol 89, 271-276.
38. Ziegler, T., Hemphill, M. L., Ziegler, M. L., Perez-Oronoz, G., Klimov, A. I., Hampson, A. W., Regnery, H. L. & Cox, N. J. (1999). Low incidence of rimantadine resistance in field isolates of influenza A viruses. J Infect Dis 180, 935-939.